GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Beneish M-Score

Star Lake Bioscience Co (SHSE:600866) Beneish M-Score : -2.91 (As of Mar. 31, 2025)


View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.91 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Star Lake Bioscience Co's Beneish M-Score or its related term are showing as below:

SHSE:600866' s Beneish M-Score Range Over the Past 10 Years
Min: -5.96   Med: -2.47   Max: 65.62
Current: -2.91

During the past 13 years, the highest Beneish M-Score of Star Lake Bioscience Co was 65.62. The lowest was -5.96. And the median was -2.47.


Star Lake Bioscience Co Beneish M-Score Historical Data

The historical data trend for Star Lake Bioscience Co's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Beneish M-Score Chart

Star Lake Bioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.67 -2.71 - -0.75 -2.67

Star Lake Bioscience Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.41 -2.67 -2.74 -2.53 -2.91

Competitive Comparison of Star Lake Bioscience Co's Beneish M-Score

For the Biotechnology subindustry, Star Lake Bioscience Co's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Star Lake Bioscience Co's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Star Lake Bioscience Co's Beneish M-Score falls into.


;
;

Star Lake Bioscience Co Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Star Lake Bioscience Co for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.3507+0.528 * 0.8186+0.404 * 0.9851+0.892 * 1.0053+0.115 * 1
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 2.264+4.679 * -0.091356-0.327 * 1.0201
=-2.91

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Sep24) TTM:Last Year (Sep23) TTM:
Total Receivables was ¥1,391 Mil.
Revenue was 4303.243 + 4286.838 + 4199.501 + 4645.087 = ¥17,435 Mil.
Gross Profit was 666.051 + 703.623 + 640.67 + 825.091 = ¥2,835 Mil.
Total Current Assets was ¥5,052 Mil.
Total Assets was ¥14,307 Mil.
Property, Plant and Equipment(Net PPE) was ¥8,204 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥436 Mil.
Total Current Liabilities was ¥4,396 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1,915 Mil.
Net Income was 171.051 + 254.685 + 251.484 + 188.553 = ¥866 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = ¥0 Mil.
Cash Flow from Operations was 1423.789 + 644.587 + -194.798 + 299.242 = ¥2,173 Mil.
Total Receivables was ¥1,024 Mil.
Revenue was 4462.202 + 4103.195 + 4163.244 + 4614.055 = ¥17,343 Mil.
Gross Profit was 649.495 + 474.031 + 492.124 + 693.098 = ¥2,309 Mil.
Total Current Assets was ¥4,069 Mil.
Total Assets was ¥13,742 Mil.
Property, Plant and Equipment(Net PPE) was ¥8,648 Mil.
Depreciation, Depletion and Amortization(DDA) was ¥0 Mil.
Selling, General, & Admin. Expense(SGA) was ¥192 Mil.
Total Current Liabilities was ¥4,602 Mil.
Long-Term Debt & Capital Lease Obligation was ¥1,341 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(1390.693 / 17434.669) / (1024.21 / 17342.696)
=0.079766 / 0.059057
=1.3507

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2308.748 / 17342.696) / (2835.435 / 17434.669)
=0.133125 / 0.162632
=0.8186

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (5051.801 + 8203.951) / 14307.226) / (1 - (4069.045 + 8647.882) / 13742.159)
=0.073493 / 0.074605
=0.9851

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=17434.669 / 17342.696
=1.0053

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0 / (0 + 8647.882)) / (0 / (0 + 8203.951))
=0 / 0
=1

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(436.405 / 17434.669) / (191.744 / 17342.696)
=0.025031 / 0.011056
=2.264

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((1915.055 + 4396.297) / 14307.226) / ((1340.597 + 4601.916) / 13742.159)
=0.44113 / 0.432429
=1.0201

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(865.773 - 0 - 2172.82) / 14307.226
=-0.091356

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Star Lake Bioscience Co has a M-score of -2.91 suggests that the company is unlikely to be a manipulator.


Star Lake Bioscience Co Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Star Lake Bioscience Co Business Description

Traded in Other Exchanges
N/A
Address
No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
Executives
Chen Wu Director
Liu Xian Yi Director
Liao Jie Ming senior management
Chen Chao Ju Director
Li Qing Lin Supervisors
Zhong Zi Rong Director

Star Lake Bioscience Co Headlines

No Headlines